332 related articles for article (PubMed ID: 19077910)
1. Brain tumor enhancement in magnetic resonance imaging: dependency on the level of protein binding of applied contrast agents.
Wintersperger BJ; Runge VM; Tweedle MF; Jackson CB; Reiser MF
Invest Radiol; 2009 Feb; 44(2):89-94. PubMed ID: 19077910
[TBL] [Abstract][Full Text] [Related]
2. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
Runge VM; Biswas J; Wintersperger BJ; Baumann SS; Jackson CB; Herborn CU; Patel T
Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
[TBL] [Abstract][Full Text] [Related]
4. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
5. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
Knopp MV; Runge VM; Essig M; Hartman M; Jansen O; Kirchin MA; Moeller A; Seeberg AH; Lodemann KP
Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
[TBL] [Abstract][Full Text] [Related]
6. Enhancement in a brain glioma model: a comparison of half-dose gadobenate dimeglumine versus full-dose gadopentetate dimeglumine at 1.5 and 3 T.
Morelli JN; Gerdes CM; Zhang W; Williams JM; Saettele MR; Ai F
J Magn Reson Imaging; 2013 Aug; 38(2):306-11. PubMed ID: 23737259
[TBL] [Abstract][Full Text] [Related]
7. Brain tumor enhancement in MR imaging at 3 Tesla: comparison of SNR and CNR gain using TSE and GRE techniques.
Wintersperger BJ; Runge VM; Biswas J; Reiser MF; Schoenberg SO
Invest Radiol; 2007 Aug; 42(8):558-63. PubMed ID: 17620938
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
[TBL] [Abstract][Full Text] [Related]
9. Comparison of contrast agents with high molarity and with weak protein binding in cerebral perfusion imaging at 3 T.
Thilmann O; Larsson EM; Björkman-Burtscher IM; Ståhlberg F; Wirestam R
J Magn Reson Imaging; 2005 Nov; 22(5):597-604. PubMed ID: 16200539
[TBL] [Abstract][Full Text] [Related]
10. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
Essig M; Tartaro A; Tartaglione T; Pirovano G; Kirchin MA; Spinazzi A
Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
[TBL] [Abstract][Full Text] [Related]
11. Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations.
Johansson L; Kirchin MA; Ahlström H
Acta Radiol; 2012 Dec; 53(10):1112-7. PubMed ID: 23081961
[TBL] [Abstract][Full Text] [Related]
12. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.
Giesel FL; Mehndiratta A; Risse F; Rius M; Zechmann CM; von Tengg-Kobligk H; Gerigk L; Kauczor HU; Politi M; Essig M; Griffiths PD; Wilkinson ID
Acta Radiol; 2009 Jun; 50(5):521-30. PubMed ID: 19337867
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the longitudinal relaxation rate of blood after gadobenate dimeglumine administration: sequence optimization, dynamic acquisition, and clinical impact for contrast-enhanced MR angiography of the carotid arteries.
Neira C; Anzidei M; Napoli A; Kirchin MA; Cavallo Marincola B; Zaccagna F; Catalano C; Passariello R; Tedoldi F
Invest Radiol; 2011 Dec; 46(12):774-82. PubMed ID: 21730871
[TBL] [Abstract][Full Text] [Related]
14. Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.
Rudolph A; von Knobelsdorff-Brenkenhoff F; Wassmuth R; Prothmann M; Utz W; Schulz-Menger J
J Magn Reson Imaging; 2014 May; 39(5):1153-60. PubMed ID: 24151119
[TBL] [Abstract][Full Text] [Related]
15. Intraindividual comparison of gadobenate dimeglumine and gadobutrol for cerebral magnetic resonance perfusion imaging at 1.5 T.
Essig M; Lodemann KP; Le-Huu M; Brüning R; Kirchin M; Reith W
Invest Radiol; 2006 Mar; 41(3):256-63. PubMed ID: 16481908
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast enhancement of experimental glioma an intra-individual comparative study to assess the optimal time delay.
Engelhorn T; Schwarz MA; Eyupoglu IY; Kloska SP; Struffert T; Doerfler A
Acad Radiol; 2010 Feb; 17(2):188-93. PubMed ID: 19910218
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
Hirschberg H; Wu GN; Madsen SJ
Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Gd-DTPA-induced signal enhancements in rat brain C6 glioma among different pulse sequences in 3-Tesla magnetic resonance imaging.
Sato H; Enmi J; Teramoto N; Hayashi T; Yamamoto A; Tsuji T; Naito H; Iida H
Acta Radiol; 2008 Mar; 49(2):172-9. PubMed ID: 18300142
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.
Pediconi F; Catalano C; Padula S; Roselli A; Dominelli V; Cagioli S; Kirchin MA; Pirovano G; Passariello R
AJR Am J Roentgenol; 2008 Nov; 191(5):1339-46. PubMed ID: 18941066
[TBL] [Abstract][Full Text] [Related]
20. Gadobutrol for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison with gadopentetate dimeglumine.
Durmus T; Schilling R; Doeblin P; Huppertz A; Hamm B; Taupitz M; Wagner M
Invest Radiol; 2012 Mar; 47(3):183-8. PubMed ID: 22183078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
